Myristic Acid-Modified DA7R Peptide for Whole-Process Glioma-Targeted Drug Delivery-Reference-Cited by-全球学者库

Myristic Acid-Modified DA7R Peptide for Whole-Process Glioma-Targeted Drug Delivery

Published:2018-05-23 Issue:23 Volume:10 Page:19473-19482
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Ying Man¹²,Wang Songli¹²,Zhang Mingfei¹²,Wang Ruifeng¹²,Zhu Hangchang¹²,Ruan Huitong¹²,Ran Danni¹²,Chai Zhilan¹²,Wang Xiaoyi¹²,Lu Weiyue¹²³^ORCID

Affiliation:

1. Department of Pharmaceutics, School of Pharmacy, Fudan University & Key Laboratory of Smart Drug Delivery (Fudan University), Ministry of Education and PLA, Shanghai 201203, China

2. State Key Laboratory of Medical Neurobiology, and Collaborative Innovation Center for Brain Science, Fudan University, Shanghai 200032, China

3. Minhang Branch, Zhongshan Hospital and Institute of Fudan-Minghang Academic Health System, Minghang Hospital, Fudan University, Shanghai 201199, China

Funder

Ministry of Science and Technology of the People's Republic of China

Shanghai Municipal Education Commission

Science and Technology Commission of Shanghai Municipality

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.8b05235

Reference44 articles.